Group One Trading’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.84K | Buy |
+7,000
| New | +$7.84K | ﹤0.01% | 1618 |
|
|
2024
Q4 | – | Sell |
-5,730
| Closed | -$9.63K | – | 2469 |
|
|
2024
Q3 | $9.63K | Sell |
5,730
-19
| -0.3% | -$32 | ﹤0.01% | 1284 |
|
|
2024
Q2 | $8.16K | Sell |
5,749
-1,475
| -20% | -$2.1K | ﹤0.01% | 1341 |
|
|
2024
Q1 | $27.4K | Buy |
+7,224
| New | +$27.4K | ﹤0.01% | 1080 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2329 |
|
|
2023
Q3 | – | Sell |
-1,100
| Closed | -$2.89K | – | 2358 |
|
|
2023
Q2 | $2.89K | Sell |
1,100
-12,399
| -92% | -$32.6K | ﹤0.01% | 1477 |
|
|
2023
Q1 | $49.1K | Hold |
13,499
| – | – | ﹤0.01% | 1014 |
|
|
2022
Q4 | $52.6K | Buy |
13,499
+13,015
| +2,689% | +$50.8K | ﹤0.01% | 1075 |
|
|
2022
Q3 | $2K | Sell |
484
-2,400
| -83% | -$9.92K | ﹤0.01% | 1795 |
|
|
2022
Q2 | $13K | Sell |
2,884
-19,685
| -87% | -$88.7K | ﹤0.01% | 1601 |
|
|
2022
Q1 | $126K | Buy |
+22,569
| New | +$126K | ﹤0.01% | 1170 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2497 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2388 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2308 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2141 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 1950 |
|